Pende, Mario

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).

Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy

Autophagy in Disease and TherapyCalcium signaling and nucleotide metabolism

Cited by 5,894

Atrophy of S6K1(−/−) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control

Ohanna, M., Sobering, A. K., Lapointe, T., Lorenzo, L., Praud, C., Petroulakis, E., Sonenberg, N., Kelly, P. A., Sotiropoulos, A., & Pende, M. (2005) · Nature Cell Biology

PI3K/AKT/mTOR signaling in cancerMuscle Physiology and Disorders

Cited by 392

Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy

Risson, V., Mazelin, L., Roceri, M., Sanchez, H., Moncollin, V., Corneloup, C., Richard-Bulteau, H., Vignaud, A., Baas, D., Defour, A., et al. (2009) · Journal of Cell Biology

Muscle Physiology and DisordersPI3K/AKT/mTOR signaling in cancer

Cited by 381

Signalling pathways regulating muscle mass in ageing skeletal muscle. The role of the IGF1-Akt-mTOR-FoxO pathway

Sandri, M., Barberi, L., Bijlsma, A. Y., Blaauw, B., Dyar, K. A., Milan, G., Mammucari, C., Meskers, C. G. M., Pallafacchina, G., Paoli, A., et al. (2013) · Biogerontology

Muscle Physiology and DisordersMuscle metabolism and nutrition

Cited by 340

Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex

Liang, N., Zhang, C., Dill, P., Panasyuk, G., Pion, D., Koka, V., Gallazzini, M., Olson, E. N., Lam, H., Henske, E. P., et al. (2014) · Journal of Experimental Medicine

Hippo pathway signaling and YAP/TAZTuberous Sclerosis Complex Research

Cited by 205

Important role for AMPKαl in limiting skeletal muscle cell hypertrophy

Mounier, R., Lantier, L., Leclerc, J., Sotiropoulos, A., Pende, M., Daegelen, D., Sakamoto, K., Foretz, M., & Viollet, B. (2009) · The FASEB Journal

Muscle Physiology and DisordersMetabolism, Diabetes, and Cancer

Cited by 133

Defects of Vps15 in skeletal muscles lead to autophagic vacuolar myopathy and lysosomal disease

Nemazanyy, I., Blaauw, B., Paolini, C., Caillaud, C., Protasi, F., Mueller, A., Proikas‐Cezanne, T., Russell, R. C., Guan, K., Nishino, I., et al. (2013) · EMBO Molecular Medicine

Autophagy in Disease and TherapyGlycogen Storage Diseases and Myoclonus

Cited by 126

The class 3 PI3K coordinates autophagy and mitochondrial lipid catabolism by controlling nuclear receptor PPARα

Iershov, A., Nemazanyy, I., Alkhoury, C., Girard, M., Barth, E., Cagnard, N., Montagner, A., Chretien, D., Rugarli, E. I., Guillou, H., et al. (2019) · Nature Communications

Autophagy in Disease and TherapyPeroxisome Proliferator-Activated Receptors

Cited by 109

S6 kinase inactivation impairs growth and translational target phosphorylation in muscle cells maintaining proper regulation of protein turnover

Mieulet, V., Roceri, M., Espeillac, C., Sotiropoulos, A., Ohanna, M., Oorschot, V., Klumperman, J., Sandri, M., & Pende, M. (2007) · American Journal of Physiology-Cell Physiology

PI3K/AKT/mTOR signaling in cancerMuscle Physiology and Disorders

Cited by 99

Desmoplakin Cardiomyopathy

Guazzo, A., Perumal Vanaja, I., Di Bona, A., Bariani, R., Disalvo, M. C., Albiero, M., Kuperwasser, N., David, P., Celeghin, R., Di Mauro, V., et al. (2026) · JACC: Clinical Electrophysiology

Cardiovascular Effects of ExerciseCardiomyopathy and Myosin Studies

Cited by 3

Coordinated maintenance of the size control of muscle cells by AMP‐activated protein kinase

Lantier, L., Mounier, R., Leclerc, J., Melki, J., Pende, M., Bertrand, L., Foretz, M., & Viollet, B. (2010) · The FASEB Journal

Metabolism, Diabetes, and CancerMuscle Physiology and Disorders

Cited by 0